A new target for differentiation therapy in AML
Despite major advances in under- standing the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are begin- ning to id...
Gespeichert in:
| Veröffentlicht in: | Cell research 2017-01, Vol.27 (1), p.9-10 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | Despite major advances in under- standing the genetics and epigenetics of acute myelogenous leukemia, there is still a great need to develop more specific and effective therapies. High throughput approaches involving either genetic approaches or small molecule inhibitor screens are begin- ning to identify promising new thera- peutic targets. |
|---|---|
| ISSN: | 1001-0602 1748-7838 |
| DOI: | 10.1038/cr.2016.130 |